"One-stop shop" spectral imaging for rapid on-site diagnosis of lung cancer: A future concept in nano-oncology

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 4533-4542

  Darwiche, Kaid ^a   Zarogoulidis, Paul ^a,b   Krauss, Leslie ^c   Oezkan, Filiz ^a   Walter, Robert Fred Henry ^a,d   Werner, Robert ^d   Theegarten, Dirk ^d   Sakkas, Leonidas ^e   Sakkas, Antonios ^e   Hohenforst Scmidt, Wolfgang ^f   Zarogoulidis, Konstantinos ^a   Freitag, Lutz ^a  

^a RUHRLANDKLINIK   (Germany)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c CytoViva Inc   (United States)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e G PAPANICOLAOU HOSPITAL   (Greece)

^f UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Diagnosis; Endobronchial ultrasound; Lung cancer; Spectral imaging

Indexed keywords

ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER TISSUE; CARCINOID; CONTROLLED STUDY; ENDOBRONCHIAL ULTRASONOGRAPHY; EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION POSITIVE LUNG ADENOCARCINOMA; EPITHELIOID MESOTHELIOMA; FIBROSING ALVEOLITIS; FLEXIBLE BRONCHOSCOPE BIOPSY FORCEPS; HUMAN; HUMAN TISSUE; ILLUMINATION; INTERSTITIAL PNEUMONIA; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG LESION; LUNG SARCOIDOSIS; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE; LYMPHOCYTOMA; MALT CELL LYMPHOMA; MESOTHELIOMA; NANOTECHNOLOGY; ONCOLOGY; RIGID BRONCHOSCOPE BIOPSY FORCEPS; SARCOMATOID MESOTHELIOMA; SMALL CELL NEUROENDOCRINE CARCINOMA; SPECTROSCOPY; THYMOMA; WEGENER GRANULOMATOSIS;

DIAGNOSIS; ENDOBRONCHIAL ULTRASOUND; LUNG CANCER; SPECTRAL IMAGING;

BRONCHOSCOPES; BRONCHOSCOPY; HISTOCYTOCHEMISTRY; HUMANS; LUNG NEOPLASMS; NANOMEDICINE; SPECTRUM ANALYSIS;

EID: 84888153012     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S54418     Document Type: Article

References (61)

1. Kaneda H, Yoshida T, Okamoto I. Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment. Cancer Manag Res. 2013;5:91-101.
2. Salama JK, Vokes EE. New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer. J Clin Oncol. 2013;31:1029-1038.
3. Boutsikou E, Kontakiotis T, Zarogoulidis P, et al. Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer. Onco Targets Ther. 2013;6:125-134.
4. Zarogoulidis K, Kontakiotis T, Hatziapostolou P, et al. A Phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer. Lung Cancer. 2001;32:281-287.
5. Zarogoulidis K, Mylonaki E, Kakavelas P, et al. Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer. Lung Cancer. 2009;66:226-230.
6. Shibuya M, Kogo M, Kurihara T, et al. [Analysis of the risk factors for severe neutropenia in advanced non-small cell lung cancer after the first course of chemotherapy with third-generation agents]. Yakugaku Zasshi. 2013;133:703-709. Japanese.
7. Zarogoulidis K, Papagiannis A, Ziogas E, et al. Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer. Eur J Cancer. 1997;33:2428-2431.
8. Zarogoulidis P, Chatzaki E, Hohenforst-Schmidt W, et al. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review. Cancer Gene Ther. 2012;19:593-600.
9. Zarogoulidis P, Petridis D, Ritzoulis C, et al. Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup. Int J Pharm. 2013;453:480-487.
10. Zarogoulidis P, Chatzaki E, Porpodis K, et al. Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine. 2012;7:1551-1572.
11. Zarogoulidis P, Eleftheriadou E, Sapardanis I, et al. Feasibility and effectiveness of inhaled carboplatin in NSCLC patients. Invest New Drugs. 2012;30:1628-1640.
12. Porpodis K, Karanikas M, Zarogoulidis P, et al. A case of typical pulmonary carcinoid tumor treated with bronchoscopic therapy followed by lobectomy. J Multidiscip Healthc. 2012;5:47-51.
13. Bolliger CT, Sutedja TG, Strausz J, Freitag L. Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Eur Respir J. 2006;27:1258-1271.
14. Zarogoulidis K, Eleftheriadou E, Kontakiotis T, et al. Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients. Lung Cancer. 2012;76: 84-88.
15. Willers H, Azzoli CG, Santivasi WL, Xia F. Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. Cancer J. 2013;19:200-207.
16. Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin. 2013;63:88-105.
17. Bunn PA Jr. Worldwide overview of the current status of lung cancer diagnosis and treatment. Arch Pathol Lab Med. 2012;136:1478-1481.
18. Darwiche K, Baumbach JI, Sommerwerck U, Teschler H, Freitag L. Bronchoscopically obtained volatile biomarkers in lung cancer. Lung. 2011;189:445-452.
19. Huttenberger D, Gabrecht T, Wagnieres G, et al. Autofluorescence detection of tumors in the human lung-spectroscopical measurements in situ, in an in vivo model and in vitro. Photodiagnosis Photodyn Ther. 2008;5:139-147.
20. Vallieres E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4:1049-1059.
21. Chien CR, Yang ST, Chen CY, et al. Impact of the new lung cancer staging system for a predominantly advanced-disease patient population. J Thorac Oncol. 2010;5:340-343.
22. Arribalzaga EB. New tumor, node, metastasis staging system for lung cancer. J Thorac Oncol. 2009;4:1301.
23. Boffa DJ, Detterbeck FC, Smith EJ, et al. Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer? J Thorac Oncol. 2010;5:1779-1783.
24. Pepek JM, Chino JP, Marks LB, et al. How well does the new lung cancer staging system predict for local/regional recurrence after surgery? A comparison of the TNM 6 and 7 systems. J Thorac Oncol. 2011;6: 757-761.
25. Zarogoulidis K, Latsios D, Porpodis K, et al. New dilemmas in small-cell lung cancer TNM clinical staging. Onco Targets Ther. 2013;6: 539-547.
26. Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA. Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2011;6:1496-1504.
27. Lee HJ, Lee CH, Jeong YJ, et al. IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications. J Thorac Imaging. 2012;27:340-353.
28. Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013;137:668-684.
29. Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013;137:685-705.
30. Kimbrell HZ, Gustafson KS, Huang M, Ehya H. Subclassification of non-small cell lung cancer by cytologic sampling: a logical approach with selective use of immunocytochemistry. Acta Cytol. 2012;56: 419-424.
31. Brocken P, van der Heijden HF, Dekhuijzen PN, Peters-Bax L, de Geus-Oei LF. High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer. Respiration. Epub April 16, 2013.
32. Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for Staging Non-Small Cell Lung Cancer: Diagnosis and Management of Lung Cancer. 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(Suppl 5):e211S-e250S.
33. Block MI. Endobronchial ultrasound for lung cancer staging: how many stations should be sampled? Ann Thorac Surg. 2010;89:1582-1587.
34. Freitag L. Flexible contra starre Bronchoskopie für die Implantation von Prothesen tracheobronchial (Stents). Pro starre Bronchoskopie [Flexible contra rigid bronchoscopy for implantation of tracheobronchial prostheses (stents). Pro rigid bronchoscopy]. Pneumologie. 1997;51:255-257. German.
35. Wohlschlager J, Darwiche K, Ting S, et al. "Rapid on-site evaluation" (ROSE) in der zytologischen Diagnostik von Lungen-und Mediastinalerkrankungen [Rapid on-site evaluation (ROSE) in cytological diagnostics of pulmonary and mediastinal diseases]. Pathologe. 2012;33:308-315. German.
36. Meyer MG, Fauver M, Rahn JR, et al. Automated cell analysis in 2D and 3D: a comparative analysis. Pattern Recognit. 2009;42:141-146.
37. Rahn JR, Meyer MG, Patten FW, Neumann T, Nelson AC. Three-dimensional imaging of single isolated cell nuclei using optical projection tomography. Opt Express. 2005;13:4210-4223.
38. Yamamoto N, Tsuchiya H, Hoffman RM. Tumor imaging with multicolor fluorescent protein expression. Int J Clin Oncol. 2011;16:84-91.
39. Gorbach AM, Ackerman HC, Liu WM, et al. Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease. Microvasc Res. 2012;84:262-269.
40. Gurjarpadhye AA, Whited BM, Sampson A, et al. Imaging and characterization of bioengineered blood vessels within a bioreactor using free-space and catheter-based OCT. Lasers Surg Med. 2013;45: 391-400.
41. Kelly KA, Carson J, McCarthy JR, Weissleder R. Novel peptide sequence ("IQ-tag") with high affinity for NIR fluorochromes allows protein and cell specific labeling for in vivo imaging. PLoS One. 2007;2:e665.
42. Kumar SR, Quinn TP, Deutscher SL. Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas. Clin Cancer Res. 2007;13:6070-6079.
43. Winnard PT Jr, Kluth JB, Kato Y, Artemov D, Raman V. Development of novel chimeric transmembrane proteins for multimodality imaging of cancer cells. Cancer Biol Ther. 2007;6:1889-1899.
44. Genzel-Boroviczeny O, Strotgen J, Harris AG, Messmer K, Christ F. Orthogonal polarization spectral imaging (OPS): a novel method to measure the microcirculation in term and preterm infants transcutaneously. Pediatr Res. 2002;51:386-391.
45. Hanssen E, Sougrat R, Frankland S, et al. Electron tomography of the Maurer's cleft organelles of Plasmodium falciparum-infected erythrocytes reveals novel structural features. Mol Microbiol. 2008;67: 703-718.
46. Lee JE, Liang KJ, Fariss RN, Wong WT. Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy. Invest Ophthalmol Vis Sci. 2008;49:4169-4176.
47. Muller O, Tian Q, Zantl R, Kahl V, Lipp P, Kaestner L. A system for optical high resolution screening of electrical excitable cells. Cell Calcium. 2010;47:224-233.
48. Saba W, Valette H, Granon S, et al. [18F]ZW-104, a new radioligand for imaging alpha2-alpha3-alpha4/beta2 central nicotinic acetylcholine receptors: Evaluation in mutant mice. Synapse. 2010;64:570-572.
49. Digilio G, Menchise V, Gianolio E, et al. Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling. J Med Chem. 2010;53:4877-4890.
50. Boros E, Ferreira CL, Yapp DT, et al. RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga. Nucl Med Biol. A2012;39:785-794.
51. Eustaquio T, Leary JF. Nanobarcoding: detecting nanoparticles in biological samples using in situ polymerase chain reaction. Int J Nanomedicine. 2012;7:5625-5639.
52. O'Riordan TC, Fitzgerald K, Ponomarev GV, et al. Sensing intracellular oxygen using near-infrared phosphorescent probes and live-cell fluorescence imaging. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1613-R1620.
53. Kaya F, Mannioui A, Chesneau A, et al. Live imaging of targeted cell ablation in Xenopus: a new model to study demyelination and repair. J Neurosci. 2012;32:12885-12895.
54. Mathis JM, Bhatia S, Khandelwal A, et al. Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging. PLoS One. 2011;6:e16792.
55. Li S, He H, Cui W, et al. Detection of Abeta plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice. Anat Rec (Hoboken). 2010;293:2136-2143.
56. Sun X, Niu G, Yan Y, et al. Phage display-derived peptides for osteosarcoma imaging. Clin Cancer Res. 2010;16:4268-4277.
57. Zarogoulidis P, Hohenforst-Schmidt W, Darwiche K, et al. 2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy. Gene Ther. 2013;20:1022-1028.
58. Vainrub A, Pustovyy O, Vodyanoy V. Resolution of 90 nm (lambda/5) in an optical transmission microscope with an annular condenser. Opt Lett. 2006;31:2855-2857.
59. Valette H, Xiao Y, Peyronneau MA, et al. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors-in vitro binding properties and PET studies in baboons. J Nucl Med. 2009;50:1349-1355.
60. Burden-Gulley SM, Qutaish MQ, Sullivant KE, et al. Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid three-dimensional detail. Cancer Res. 2011;71:5932-5940.
61. Darwiche K, Wagner M, Theegarten D. Aktueller Stellenwert des endobronchialen Ultraschalls (EBUS) [Current value of endobronchial ultrasound (EBUS)]. Pneumologie. 2011;65:537-548. German.